メリーランド州における過体重の臨床試験
メリーランド州内の拠点で、過体重に関する37件の研究が参加者を募集しています。
メリーランド州内の都市
公式研究テキスト（英語）
Effects of Sucralose on Drug Absorption and Metabolism (The SweetMeds Study)
- National Institutes of Health Clinical Center, Bethesda
被験者募集中第2相健康なボランティア歓迎
18歳〜60歳 · 女性 · 2026/10/02更新 · NCT03407079A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
- Barry J. Reiner, MD LLC, Baltimore
被験者募集中第3相
8歳〜18歳 · 全性別 · 2026/09/30更新 · NCT07253285Physical and Behavioral Traits of Overweight and Obese Adults
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
18歳〜100歳 · 全性別 · 2026/09/28更新 · NCT00428987A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
- Centennial Medical Group, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07794579A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/28更新 · NCT07595549A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
- Research Site, Beltsville
- Research Site, Oxon Hill
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07776509Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Capital Digestive Care - Chevy Chase, Chevy Chase
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937099A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
- Johns Hopkins Children's Center, Baltimore
被験者募集中第3相
6歳〜17歳 · 全性別 · 2026/09/24更新 · NCT06672549Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Capital Digestive Care - Chevy Chase, Chevy Chase
被験者募集中第3相
18歳〜70歳 · 全性別 · 2026/09/24更新 · NCT06937086A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
- Centennial Medical Group, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07282600A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
- Centennial Medical Group, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07392190A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Beltsville
- Research Site, Lanham
- Research Site, Oxon Hill
- 他1件
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07784270A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight
- Flourish Research - Bowie, Bowie
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07369011Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
- Ascension Saint Agnes Heart Care, Baltimore
- MD Medical Research, Oxon Hill
- Velocity Clinical Research - Rockville, Rockville
被験者募集中第3相
45歳〜99歳 · 全性別 · 2026/09/22更新 · NCT07037433A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
- MedStar Good Samaritan Hospital, Baltimore
- MedStar Health Research Institute (MedStar Physician Based Research Network), Hyattsville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07321886Effect of Nicotinamide Riboside on Ketosis, Fat Oxidation & Metabolic Rate
- National Institutes of Health Clinical Center, Bethesda
被験者募集中
18歳〜65歳 · 全性別 · 2026/09/18更新 · NCT06044935A Study to Investigate the Effect of AZD6234, AZD9550, and a Combination of AZD9550 and AZD6234 on Pharmacokinetics of Combined Oral Contraceptive Ethinyl Estradiol/Levonorgestrel in Healthy Female Participants Living With Overweight or Obesity
- Research Site, Brooklyn
被験者募集中第1相健康なボランティア歓迎
35歳〜75歳 · 女性 · 2026/09/17更新 · NCT07013643Youth-Onset Type 2 Diabetes and Heart Disease: The Young at Heart Prospective Cohort Study
- National Institutes of Health Clinical Center, Bethesda
被験者募集中観察研究健康なボランティア歓迎
12歳〜25歳 · 全性別 · 2026/09/17更新 · NCT06730113A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
- AURORA-1 Clinical Site, Bowie
- AURORA-1 Clinical Site, Rockville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743463A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Bowie
- AURORA-2 Clinical Site, Rockville
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/16更新 · NCT07743450A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
- Centennial Medical Group, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351058A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
- Baltimore VA Medical Center, Baltimore
- Johns Hopkins University School of Nursing, Baltimore
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/14更新 · NCT07351045A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
- ACCOMPLISH-2 Research Site, Silver Spring
被験者募集中第3相健康なボランティア歓迎
18歳〜79歳 · 全性別 · 2026/09/11更新 · NCT07654374A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
- PAREXEL Intl - EPCU-Baltimore, Baltimore
被験者募集中第1相
18歳〜55歳 · 全性別 · 2026/09/09更新 · NCT07566390Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
- Johns Hopkins University, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/09更新 · NCT06847399A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
- Dermatology and Skin Cancer Specialists, LLC, Rockville
被験者募集中第4相
18歳以上 · 全性別 · 2026/09/04更新 · NCT06857942Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
- Kailera Clinical Site, Annapolis
- Kailera Clinical Site, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284901Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
- Kailera Clinical Site, Columbia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/03更新 · NCT07284875Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
- ACCOMPLISH-1 Research Site, Silver Spring
被験者募集中第3相
18歳〜79歳 · 全性別 · 2026/08/10更新 · NCT07654361Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
- National Institutes of Health Clinical Center, Bethesda
被験者募集中
18歳〜50歳 · 全性別 · 2026/07/31更新 · NCT06325722Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
- Johns Hopkins School of Nursing, Baltimore
被験者募集中
18歳以上 · 女性 · 2026/06/08更新 · NCT05619705A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity
- Parexel International-EPCU Baltimore, Baltimore
被験者募集中第1/2相健康なボランティア歓迎
18歳〜60歳 · 全性別 · 2026/06/02更新 · NCT06842186Night Owl Metabolism
- Johns Hopkins School of Medicine, Baltimore
被験者募集中健康なボランティア歓迎
18歳〜23歳 · 全性別 · 2026/05/11更新 · NCT06507722Trial of Food Is Medicine Approaches for Obesity Treatment in Adults With Food Insecurity
- Johns Hopkins University, Baltimore
被験者募集中
18歳以上 · 全性別 · 2026/03/16更新 · NCT07396805Metformin IN Asthma for Overweight and Obese Individuals (MINA)
- Johns Hopkins University, Baltimore
被験者募集中第2相
18歳以上 · 全性別 · 2026/01/16更新 · NCT06273072Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors
- Breast Evaluation and Treatment Program, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore
被験者募集中
全年齢 · 女性 · 2025/12/23更新 · NCT07032545Evaluate the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of BGM1812 Injection Following Single and Multiple Subcutaneous Administration in Normal to Overweight or Obese But Otherwise Healthy Men and Women
- Pharmaron CPC, Inc, Baltimore
被験者募集中第1相健康なボランティア歓迎
18歳〜55歳 · 全性別 · 2025/11/06更新 · NCT07224399ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。